6-K

GOLD FIELDS LTD (GFI)

6-K 2023-03-01 For: 2023-03-01
View Original
Added on April 07, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Dated 1 March 2023

Commission File Number 001-31318

Gold Fields Limited

(Translation of registrant’s name into English)

150 Helen Rd.

Sandown, Sandton 2196

South Africa

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒  Form 20-F ☐  Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Gold Fields Limited
Date: 1 March 2023 By: /s/ Martin Preece
Name: Martin Preece
Title: Interim Chief Executive Officer

INDEX TO EXHIBITS

No. Exhibit
99.1 Gold Fields Limited SENS Announcement
99.2 Gold Fields Limited SENS Announcement

gfldirectorsdealings991

Gold Fields Limited Reg. No. 1968/004880/06) (Incorporated in the Republic of South Africa) JSE, NYSE, DIFX Share Code: GFI ISIN Code:ZAE000018123 (“Gold Fields” or the “Company”) DEALING IN SECURITIES BY A PRESCRIBED OFFICER In compliance with paragraphs 3.63 to 3.74 of the Listings Requirements of JSE Limited ("the Listings Requirements") the Company hereby advises that directors and prescribed Officers of Gold Fields and directors of major subsidiaries of the Company accepted their Performance Shares which were awarded in terms of the Gold Fields 2012 Share Plan (“Scheme”) as amended. Accordingly, the following trades are announced: Name of Director, Prescribed Officer, Director of Major subsidiary A Munt Nature of transaction On market sale of shares in terms of the above scheme Class of Security Ordinary shares Nature of interest Direct and Beneficial Transaction Date 24/02/2023 Number of Shares traded 21,097 Number of Shares retained 0 Market Price per share R165.4372 Total Value R3,490,228.61 Name of Director, Prescribed Officer, Director of Major subsidiary G Ovens Nature of transaction On market sale of shares in terms of the above scheme Class of Security Ordinary shares Nature of interest Direct and Beneficial Transaction Date 24/02/2023 Number of Shares traded 21,610 Number of Shares retained 0 Market Price per share R165.4372 Total Value R3,575,097.89 Name of Director, Prescribed Officer, Director of Major subsidiary L Rivera Nature of transaction On market sale of shares in terms of the above scheme Class of Security Ordinary shares Nature of interest Direct and Beneficial Transaction Date 24/02/2023 Number of Shares traded 165,916 Number of Shares retained 0 Market Price per share R165.4372 Total Value R27,448,678.48


Name of Director, Prescribed Officer, Director of Major subsidiary S Mathews Nature of transaction On market sale of shares in terms of the above scheme Class of Security Ordinary shares Nature of interest Direct and Beneficial Transaction Date 24/02/2023 Number of Shares traded 146,798 Number of Shares retained 0 Market Price per share R165.4372 Total Value R24,285,850.09 Name of Director, Prescribed Officer, Director of Major subsidiary PA Schmidt Nature of transaction On market sale of shares in terms of the above scheme Class of Security Ordinary shares Nature of interest Direct and Beneficial Transaction Date 24/02/2023 Number of Shares traded 296,009 Number of Shares retained 0 Market Price per share R165.4372 Total Value R48,970,900.13 Name of Director, Prescribed Officer, Director of Major subsidiary TL Leishman Nature of transaction On market sale of shares in terms of the above scheme Class of Security Ordinary shares Nature of interest Direct and Beneficial Transaction Date 24/02/2023 Number of Shares traded 118,330 Number of Shares retained 0 Market Price per share R165.4372 Total Value R19,576,183.88 Name of Director, Prescribed Officer, Director of Major subsidiary P Matete Nature of transaction On market sale of shares in terms of the above scheme Class of Security Ordinary shares Nature of interest Direct and Beneficial Transaction Date 24/02/2023 Number of Shares traded 6,724 Number of Shares retained 0 Market Price per share R165.4372 Total Value R1,112,399.73 Name of Director, Prescribed Officer, Director of Major subsidiary P Woodhouse Nature of transaction On market sale of shares in terms of the above scheme Class of Security Ordinary shares Nature of interest Direct and Beneficial Transaction Date 24/02/2023


Number of Shares traded 15,944 Number of Shares retained 0 Market Price per share R165.4372 Total Value R2,637,730.72 Name of Director, Prescribed Officer, Director of Major subsidiary M Preece Nature of transaction On market sale of shares in terms of the above scheme Class of Security Ordinary shares Nature of interest Direct and Beneficial Transaction Date 24/02/2023 Number of Shares traded 52,159 Number of Shares retained 60,011 Market Price per share R165.4372 Total Value Traded R8,629,038.91 In terms of paragraph 3.66 of the Listings requirements the necessary clearance to deal in the above securities has been obtained. 27 February 2023 Sponsor: J.P. Morgan Equities South Africa (Pty) Ltd


gfldirectorsdealings992

Gold Fields Limited Reg. No. 1968/004880/06) (Incorporated in the Republic of South Africa) JSE, NYSE, DIFX Share Code: GFI ISIN Code:ZAE000018123 (“Gold Fields” or the “Company”) DEALING IN SECURITIES BY A PRESCRIBED OFFICER In compliance with paragraphs 3.63 to 3.74 of the Listings Requirements of JSE Limited ("the Listings Requirements") the Company hereby advises that a prescribed Officer of Gold Fields accepted his Performance Shares which were awarded in terms of the Gold Fields 2012 Share Plan (“Scheme”) as amended. Accordingly, the following trade is announced: Name of Prescribed Officer BJ Mattison Nature of transaction On market sale of shares in terms of the above scheme Class of Security Ordinary shares Nature of interest Direct and Beneficial Transaction Date 27/02/2023 Number of Shares traded 67,339 Number of Shares retained 77,478 Market Price per share R167.6851 Total Value R11,291,746.95 In terms of paragraph 3.66 of the Listings requirements the necessary clearance to deal in the above securities has been obtained. 1 March 2023 Sponsor: J.P. Morgan Equities South Africa (Pty) Ltd